Leveraging high-throughput analytics and automation to rapidly develop high-concentration mAb formulations: integrated excipient compatibility and viscosity screening.

Antib Ther · 2024 · PMC11646310 · PMID 39678259

Europe PMC DOI

hedged sentences

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

Only factors that are statistically highly significant (e.g., p < 0.001) were included in the discussion.

also in 132,142 other papers

an overall trendno p-value reported

An overall trend similar to that of D_LMW was observed for formulations in Na-acetate and Na-succinate.

also in 4,871 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.